Here below are the publications (7) participated by Marco Valgimigli using the term string monotherapy (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch
1) P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial

is currently collaborating with
Istituto Cardiocentro Ticino (ICCT) (Rif. ICCT)
Via Tesserete 48
6900 Lugano
Marco Valgimigli
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently participating in the Research Group
Ricerca Cardiovascolare
as Group Leader [Rif. 55110]
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently participating in the Research Group
Ricerca Cardiovascolare
as Group Leader [Rif. 55110]
Marco Valgimigli
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently Research Program Leader [Rif. 50110] for
Ricerca Clinica (Rif. 10000 2023)
on behalf of
Istituto Cardiocentro Ticino (ICCT) EOC (Rif. ICCT)
is currently Research Program Leader [Rif. 50110] for
Ricerca Clinica (Rif. 10000 2023)